Danaher Stock Buy or Sell? DHR Stocks Forecast

Market Capitalization: 179 849 249 000 $
EBITDA: 10 964 000 000 $
Price to Earnings: 25.58
Quarterly Earnings Growth YOY: 0.239
Quarterly Revenue Growth YOY: 0.027
Trailing PE: 25.58
Forward PE: 25.91
Shares Outstanding: 728577000

Danaher Stock Buy or Sell? DHR Stocks Analytic Forecasts

March 31, 2023 (22:44)

Danaher Corp. (DHR) Sector: Healthcare

We present you the most up-to-date and complete review of analytical trend forecasts and views on the DHR stock market. Experts share their opinions on what to expect from the Danaher Corp. stock market. How likely is the stock price to move in a bullish or bearish trend. Which should help you to make the right decision whether to Buy or Sell Danaher stocks.

Danaher Corp. Stock Market Experts’ Analysis and Forecasting – Sell or Buy DHR Shares?

The most recent analytical view which can help you to answer the worrying question: Should I Buy Stocks Now or Wait? came out under the authorship of Deep Value Ideas and is titled

“Danaher: How To Benefit From A Yield Booster And Potential Arbitrage Profit”

is published on March 15 (2023) and has 2 likes. The review predicts Neutral market trend.

It summarize the following theses:

  • In 2019 and 2020, Danaher Inc. issued mandatory convertible preferred stock. The former DHR.PA was converted in April 2022 and the latter DHR.PB is due for conversion in April 2023.
  • DHR.PB offers an implied temporary dividend yield of 4.16% p.a. for those looking to establish a position in DHR stock, and occasionally a small but nice arbitrage opportunity.
  • Given the considerable spread between DHR and the Threshold Appreciation Price of $199.68, the downside risk is de facto irrelevant. Also, the final dividend payment has already been announced.

The author starts his analytic review with the following:

Introduction Danaher Corp. (NYSE:DHR), the life sciences, diagnostics and environmental analytics conglomerate, is an impressive company – no question about it. I covered the stock extensively in mid-December 2022, noting its renowned profitability, management’s knack for acquisitions and secular tailwinds for the industry. While Danaher stock rightly commands a premium valuation, I still found the expansion of valuation multiples over the years to be quite excessive. The ongoing bear market has brought DHR’s valuation at least somewhat back into proportion – the stock is about 25% down from its all-time high – but not enough to make it a compelling long-term investment, in my opinion.

The opinion of the author can be considered quite authoritative.
The number of 4909 followers confirms this.
Deep Value Ideas is the contributor of experts community
since 2018 and has 158 works published.

One more noteworthy article is written by WideAlpha under the title

“Danaher Vs. Agilent: Which Is The Better Option For Long-Term Investors”

on March 15 (2023) and has 5 likes. The expert reflects Neutral trend of the market.

Нis theses make you think about whether to add DHR stocks to your investment portfolio or not, and helps to work out your own Danaher stock selling strategies:

  • Agilent and Danaher have significantly outperformed the market, and have solid competitive advantages.
  • The laboratory equipment and measurement devices industry is forecasted to grow at a ~7% CAGR to the year 2030.
  • While we believe that both companies are trading close to fair value, there is one we currently find more attractive.

WideAlpha starts analysis with such words:

The laboratory equipment and measurement devices industry is particularly attractive, as it has good economics and is fairly resilient. Two companies we particularly like are Agilent Technologies (NYSE:A) and Danaher (NYSE:DHR), both of which have delivered outstanding returns for their investors and have a reputation of being very well managed.

The opinion of the author can be considered quite authoritative.
The number of 4214 followers confirms this.
WideAlpha is the contributor of experts community since 2018. Has already published at least 434 articles.

Another analysis presented by Leo Nelissen came out on March 6 (2023). Obviously, coupled with the newer reviews, this forecasting could be useful to find out the best trading strategy for DHR stocks. It sounds like

“Danaher: The Secret To Successful (Dividend) Investing”

Article has got 17 likes at the moment and forecasting Bullish trend of the market.

Summarizing the information presented in the review concerning the Danaher Corp., the expert says the following:

  • In this article, we discuss one of my favorite dividend growth stocks, which makes up for a low yield by being a consistent source of outperforming total returns.
  • The company has a stellar high-moat M&A-driven business model with strong pricing power and often anti-cyclical customers.
  • While I expect the stock to remain rangebound, I am a consistent buyer, as I believe that DHR shares will continue to beat the market.

And here, what comes first:

Introduction The other day, I wrote an article titled “The Dividend Pyramid: Potentially Beating The Market With This 12-Stock Portfolio”. The article aimed to provide investors with a theoretical analysis of two major diversification methods. One of them was the behavioral method, which I explained using the pyramid below. The behavioral method suggests that investors build a base of safe, income-generating investments while adding highly speculative investments at the top of the pyramid – to get rich quickly. However, when done correctly, investors can use safe, high-quality growth stocks to optimize the risk/reward of their portfolios. As we can see below, I included the Danaher Corporation (NYSE:DHR) in the growth category of the pyramid.

This author is very popular among the auditory. He has 21884 followers.

Leo Nelissen is the contributor of experts community since 2015 and has at least 1867 analytic reviews published.

The Share Price of Danaher Corp. (DHR) for now

What analysts predict: $302.3
52-week high/low: $303.24 / $233.03

50/200 Day Moving Average: $255.63 / $263.92

The average stock price over the previous 50/200 days. For Danaher stocks, the 50-day moving average is the resistance level for now. For DHR stocks, the 200-day moving average is the resistance level today.

See the Detailed Predictions for DHR stock with charts and tables

Related Analysis

View all analytics

Buy or Sell ADGI shares?
January 1, 1970

Bright Green Files For U.S. Direct Listing

Buy or Sell BGXX shares? Bright Green Files For U.S. Direct Listing
April 6, 2022
Bright Green Corporation has filed initial information for a direct listing on the Nasdaq Capital Market.

Eli Lilly: Best-Now Near-Term Price Gains Pharmaceuticals Stock

Buy or Sell LLY shares? Eli Lilly: Best-Now Near-Term Price Gains Pharmaceuticals Stock
March 23, 2023
84% of shares held by 3370 “institutional” investors, with over 80% of its $315 Billion market capitalization traded in a year.

If You Like Johnson & Johnson, You’ll Love These Higher-Yielding SWANs

Buy or Sell JNJ shares? If You Like Johnson & Johnson, You’ll Love These Higher-Yielding SWANs
March 10, 2023
Recession is coming and with it plenty of scary headlines about crashing stock prices and financial doom.